The "Von Willebrand Disease Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.Senior executives navigating the rare disease pharmaceutical sector ...

The Von Willebrand Disease Treatment Market offers growth through biologic and recombinant therapies, individualized care, ...

Side effects that have been reported with VONVENDI include: headache, nausea, vomiting, tingling or burning at infusion site, ...

With dosing underway in a pivotal phase 3 trial, Star Therapeutics is illuminating the clinical potential of its ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Despite ...

In this Q&A, Gianluca Bini, DVM, MRCVS, DACVAA, answers some questions surrounding bleeding in surgery. He discusses triage steps, von Willebrand disease, common mistakes made when administering blood ...

Vonvendi is now approved for routine prophylaxis to reduce bleeding frequency in adults with all types of VWD (Type 1, 2, and 3). The Food and Drug Administration (FDA) has expanded the approval of ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Star Therapeutics, a clinical stage biotechnology company discovering and developing best-in-class antibodies, today announced interim clinical data from ...

Von Willebrand disease in dogs is the most common inherited blood disorder our canine friends suffer with, and it also happens in humans and many other species. It’s a bleeding disorder – a failure of ...

Von Willebrand disease (vWD) is the most common inherited bleeding disorder and affects approximately 1% of the population. Scientists from Cleveland Clinic and Cornell University have designed a ...

Von Willebrand disease (vWD) is the most common inherited bleeding disorder and affects approximately 1% of the population. This disease is due to a deficiency of Von Willebrand factor (vWF), which is ...

Von Willebrand’s disease is a genetic condition that occurs in individuals with a deficiency in or impairment of the protein von Willebrand’s factor. These patients experience excessive bleeding and ...